Emerald Health Pharmaceuticals
PrivateLast Round
Private Placement
Mar 28, 2021
Est. Valuation
$132.4M
Total Funding Raised
$328,500
Company Overview
Emerald Health Pharmaceuticals operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Private Placement round in March 2021.
Emerald Health Pharmaceuticals is a biotechnology company that develops novel therapeutic molecules derived from synthetic cannabinoids to treat neurodegenerative, autoimmune, inflammatory, and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emerald Health Pharmaceuticals Comparables
Compare Emerald Health Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synendos Therapeutics | 75% | |
| Minoryx Therapeutics | 74% | |
| InMed Pharmaceuticals | 71% |
For institutional investors. Book with your work email.
Emerald Health Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 28, 2021 | ||||
| Seed | Jun 30, 2019 | ||||
| Private Placement | Jun 27, 2019 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2025
Grew 25% QoQ from 12 to 15 employees.
- Mar 28, 2021
$43M raised in a private placement round.
For institutional investors. Book with your work email.
Emerald Health Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Emerald Health Pharmaceuticals's valuation, stock price, and market status.
Is Emerald Health Pharmaceuticals a public or private company?
Emerald Health Pharmaceuticals is a private company.
What is the current stock price of Emerald Health Pharmaceuticals?
Emerald Health Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Emerald Health Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Emerald Health Pharmaceuticals worth (valuation)?
Emerald Health Pharmaceuticals's valuation is estimated at $132.4M based on funding round data.
Can I buy Emerald Health Pharmaceuticals stock?
Emerald Health Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Emerald Health Pharmaceuticals's last funding round?
Emerald Health Pharmaceuticals's most recent funding round was Private Placement on March 28, 2021.
Who are the main investors in Emerald Health Pharmaceuticals?
Investor information for Emerald Health Pharmaceuticals is not publicly disclosed.
Will Emerald Health Pharmaceuticals IPO soon?
No public IPO plans have been announced for Emerald Health Pharmaceuticals.
How can I track Emerald Health Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Emerald Health Pharmaceuticals's shares on secondary markets.